CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Balance Sheet Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 10:22:46 2024-09-19 am EDT			5-day change	1st Jan Change
210.85 ^USD	+2.30%		+8.11%	-11.13%

Sep. 17	Charles River Laboratories, CEBINA Partner to Accelerate Neurodegenerative Drug Development	MT
Sep. 10	Transcript : Charles River Laboratories International, Inc. Presents at Baird's 2024 Global Healthcare Conference, Sep-10-2024 10:15 AM

aa093e3d7a543b83ac665fe6b.mK0Y3QvndeoTAq6TgNcmhJdxTQFvAGiHrQ2_6-agf1k.8sJ8lXKELd0gesbU4uBR4NNCOkk6cyftgGrdh57tOi_o4G-ofYMMn0x4yQ

Published financial data: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	2.62B	2.92B	3.54B	3.98B	4.13B
Total Revenues	2.62B	2.92B	3.54B	3.98B	4.13B
Cost of Goods Sold, Total	1.66B	1.85B	2.2B	2.51B	2.6B
Gross Profit	965M	1.08B	1.34B	1.46B	1.53B
Selling General & Admin Expenses, Total	508M	527M	578M	658M	736M
Amortization of Goodwill and Intangible Assets - (IS)	89.54M	112M	125M	147M	137M
Other Operating Expenses, Total	598M	639M	703M	804M	873M
Operating Income	367M	440M	634M	659M	656M
Interest Expense, Total	-60.88M	-86.43M	-73.91M	-59.29M	-137M
Interest And Investment Income	1.52M	834K	652K	780K	5.2M
Net Interest Expenses	-59.36M	-85.6M	-73.26M	-58.51M	-132M
Income (Loss) On Equity Invest.	20.71M	101M	-30.42M	-26.78M	97.83M
Currency Exchange Gains (Loss)	-9.6M	11.9M	-31.8M	-46.53M	-
Other Non Operating Income (Expenses)	2.38M	3.28M	5.06M	-18.4M	-96.68M
EBT, Excl. Unusual Items	321M	471M	504M	508M	526M
Restructuring Charges	-13.84M	-12.59M	-6.86M	-	-29.68M
Merger & Related Restructuring Charges	-3.3M	-1.2M	-39.1M	-8.74M	-12.38M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	22.7M	123M	-961K
Asset Writedown	-	-	-	-	-
Other Unusual Items	-	-9.83M	-	-	98.5M
EBT, Incl. Unusual Items	304M	447M	481M	623M	581M
Income Tax Expense	50.02M	81.81M	81.87M	130M	101M
Earnings From Continuing Operations	254M	365M	399M	493M	480M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	254M	365M	399M	493M	480M
Minority Interest	-2.04M	-1M	-7.86M	-6.38M	-5.75M
Net Income - (IS)	252M	364M	391M	486M	475M
Net Income to Common Incl Extra Items	252M	364M	391M	486M	475M
Net Income to Common Excl. Extra Items	252M	364M	391M	486M	475M
Per Share Items
Net EPS - Basic	5.17	7.35	7.77	9.57	9.27
Basic EPS - Continuing Operations	5.17	7.35	7.77	9.57	9.27
Basic Weighted Average Shares Outstanding	48.73M	49.55M	50.29M	50.81M	51.23M
Net EPS - Diluted	5.07	7.2	7.6	9.48	9.22
Diluted EPS - Continuing Operations	5.07	7.2	7.6	9.48	9.22
Diluted Weighted Average Shares Outstanding	49.69M	50.61M	51.42M	51.3M	51.45M
Normalized Basic EPS	4.08	5.92	6.11	6.13	6.3
Normalized Diluted EPS	4	5.79	5.97	6.07	6.28
Supplemental Items
EBITDA	565M	675M	900M	962M	970M
EBITA	457M	552M	759M	805M	794M
EBIT	367M	440M	634M	659M	656M
EBITDAR	599M	714M	951M	1.04B	1.06B
Total Revenues (As Reported)	2.62B	2.92B	3.54B	3.98B	4.13B
Effective Tax Rate - (Ratio)	16.45	18.3	17.03	20.93	17.36
Current Domestic Taxes	28.02M	44.82M	41.98M	94.84M	66.91M
Current Foreign Taxes	43.49M	35.41M	60.2M	68.64M	85.36M
Total Current Taxes	71.5M	80.22M	102M	163M	152M
Deferred Domestic Taxes	-4.37M	-4M	-34.2M	-31.97M	-52.13M
Deferred Foreign Taxes	-17.11M	5.58M	13.89M	-1.13M	779K
Total Deferred Taxes	-21.48M	1.58M	-20.31M	-33.11M	-51.35M
Normalized Net Income	199M	293M	307M	311M	323M
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	2.95M	1.31M	1.28M	1.44M	1.48M
Non-Cash Pension Expense	1.19M	16.05M	-889K	2.16M	3.15M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Net Rental Expense, Total	34.11M	38.76M	50.78M	74.68M	89.05M
Imputed Operating Lease Interest Expense	9M	12.81M	11.75M	11.61M	31.04M
Imputed Operating Lease Depreciation	25.11M	25.95M	39.04M	63.06M	58.02M
Stock-Based Comp., COGS (Total)	9.04M	10.64M	13.09M	14.85M	15.05M
Stock-Based Comp., SG&A Exp. (Total)	48.23M	45.7M	58.39M	58.76M	57M
Total Stock-Based Compensation	57.27M	56.34M	71.47M	73.62M	72.05M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	238M	228M	241M	234M	277M
Short Term Investments	941K	1.02M	1.06M	-	-
Total Cash And Short Term Investments	239M	229M	242M	234M	277M
Accounts Receivable, Total	514M	618M	643M	752M	780M
Total Receivables	514M	618M	643M	752M	780M
Inventory	161M	186M	199M	256M	380M
Prepaid Expenses	52.59M	96.71M	93.54M	89.34M	87.88M
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	431K	3.07M	4.02M	6.19M	5.8M
Other Current Assets, Total	54.66M	68.46M	92.22M	101M	77.58M
Total Current Assets	1.02B	1.2B	1.27B	1.44B	1.61B
Gross Property Plant And Equipment	2.16B	2.39B	2.69B	3.02B	3.37B
Accumulated Depreciation	-978M	-1.09B	-1.1B	-1.16B	-1.34B
Net Property Plant And Equipment	1.18B	1.3B	1.58B	1.86B	2.03B
Long-term Investments	123M	222M	201M	312M	244M
Goodwill	1.54B	1.81B	2.71B	2.85B	3.1B
Other Intangibles, Total	689M	788M	1.06B	955M	864M
Deferred Tax Assets Long-Term	44.66M	37.73M	40.23M	41.26M	40.28M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	89.64M	131M	152M	148M	309M
Total Assets	4.69B	5.49B	7.02B	7.6B	8.2B
Liabilities
Accounts Payable, Total	111M	122M	198M	206M	169M
Accrued Expenses, Total	298M	357M	475M	417M	441M
Current Portion of Long-Term Debt	35.55M	47.2M	101K	1.35M	3.17M
Current Portion of Leases	23.35M	27.69M	35.96M	48.86M	57.31M
Current Income Taxes Payable	26.07M	24.88M	26.16M	39.9M	38.8M
Unearned Revenue Current, Total	205M	250M	279M	356M	327M
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	11.1M	10.68M	18.7M	22.83M	18.38M
Total Current Liabilities	710M	840M	1.03B	1.09B	1.06B
Long-Term Debt	1.82B	1.9B	2.64B	2.68B	2.62B
Long-Term Leases	144M	182M	278M	418M	445M
Unearned Revenue Non Current	20.98M	19.48M	20.58M	25.8M	30.92M
Pension & Other Post Retirement Benefits	80.83M	74.23M	105M	-	-
Deferred Tax Liability Non Current	167M	217M	240M	216M	191M
Other Non Current Liabilities	81.12M	112M	117M	149M	192M
Total Liabilities	3.03B	3.35B	4.43B	4.58B	4.54B
Common Stock, Total	489K	498K	505K	509K	513K
Additional Paid In Capital	1.53B	1.63B	1.72B	1.8B	1.91B
Retained Earnings	280M	625M	981M	1.43B	1.89B
Treasury Stock	-	-	-	-	-
Comprehensive Income and Other	-178M	-139M	-165M	-262M	-196M
Total Common Equity	1.63B	2.11B	2.53B	2.98B	3.6B
Minority Interest	31.89M	29.07M	57.17M	47.21M	62.12M
Total Equity	1.67B	2.14B	2.59B	3.02B	3.66B
Total Liabilities And Equity	4.69B	5.49B	7.02B	7.6B	8.2B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	48.96M	49.78M	50.49M	50.99M	51.35M
ECS Total Common Shares Outstanding	48.94M	49.77M	50.48M	50.94M	51.34M
Book Value / Share	33.4	42.49	50.21	58.42	70.06
Tangible Book Value	-595M	-482M	-1.24B	-829M	-362M
Tangible Book Value Per Share	-12.17	-9.69	-24.53	-16.27	-7.06
Total Debt	2.02B	2.16B	2.95B	3.15B	3.13B
Net Debt	1.79B	1.93B	2.71B	2.91B	2.85B
Debt Equivalent of Unfunded Proj. Benefit Obligation	90.23M	42.72M	36.97M	13.01M	21.22M
Debt Equivalent Oper. Leases	273M	310M	406M	597M	712M
Minority Interest, Total (Incl. Fin. Div)	31.89M	29.07M	57.17M	47.21M	62.12M
Equity Method Investments, Total	109M	197M	150M	312M	244M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	24.61M	28.32M	33.12M	38.89M	42.3M
Inventories - Work In Process, Total	35.85M	36.76M	40.27M	48.37M	59.73M
Inventories - Finished Goods, Total	100M	121M	126M	169M	278M
Land - (BS)	63.08M	61.03M	59.49M	58.19M	79.55M
Buildings, Total	1.01B	1.06B	988M	964M	1.05B
Machinery, Total	800M	892M	1B	1.11B	1.28B
Full Time Employees	17.1K	18.4K	18.6K	20K	20.4K
Part Time Employees	-	-	1.4K	1.4K	1.4K
Accumulated Allowance for Doubtful Accounts (Supple)	3.66M	6.7M	7.18M	11.28M	25.72M
Order Backlog	1.19B	1.65B	2.8B	3.5B	3.13B

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	252M	364M	391M	486M	475M
Depreciation & Amortization - CF	109M	123M	141M	157M	177M
Amortization of Goodwill and Intangible Assets - (CF)	89.54M	112M	125M	147M	137M
Depreciation & Amortization, Total	198M	235M	266M	304M	314M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-25.03M	-123M	961K
Asset Writedown & Restructuring Costs	-	-	-	-	41.91M
(Income) Loss On Equity Investments - (CF)	-20.71M	-101M	30.42M	26.78M	-97.83M
Stock-Based Compensation (CF)	57.27M	56.34M	71.47M	73.62M	72.05M
Provision and Write-off of Bad Debts	-	-	-	6.71M	18.22M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	-11.92M	18.14M	-15.53M	-1.6M	-37.79M
Change In Accounts Receivable	-8.32M	-85.63M	-26.63M	-151M	-33.43M
Change In Inventories	-21.4M	-18.38M	-25.16M	-78.52M	-62.3M
Change In Accounts Payable	29.78M	748K	44.9M	-2.65M	-20.43M
Change in Unearned Revenues	-14.52M	37.6M	3.52M	88.12M	-37.31M
Change In Income Taxes	-	-	-	-	-
Change in Other Net Operating Assets	20.64M	39.38M	46.31M	-8.92M	51.09M
Cash from Operations	481M	547M	761M	620M	684M
Capital Expenditure	-141M	-167M	-229M	-325M	-319M
Cash Acquisitions	-516M	-419M	-1.29B	-283M	-195M
Divestitures	-	-	123M	163M	-
Investment in Marketable and Equity Securities, Total	-21.4M	-15.29M	-39.02M	-154M	-47.55M
Other Investing Activities, Total	-3.89M	-1.06M	264K	-9.35M	-2.29M
Cash from Investing	-682M	-602M	-1.44B	-608M	-563M
Long-Term Debt Issued, Total	3.36B	2.23B	6.95B	2.95B	776M
Total Debt Issued	3.36B	2.23B	6.95B	2.95B	776M
Long-Term Debt Repaid, Total	-3.12B	-2.2B	-6.24B	-2.93B	-852M
Total Debt Repaid	-3.12B	-2.2B	-6.24B	-2.93B	-852M
Issuance of Common Stock	34.55M	46.59M	45.65M	25.11M	25.6M
Repurchase of Common Stock	-18.09M	-23.98M	-40.71M	-38.65M	-24.16M
Other Financing Activities, Total	-18.4M	-5.95M	-40.58M	-48.65M	-11.64M
Cash from Financing	232M	47.25M	673M	-42.4M	-85.52M
Foreign Exchange Rate Adjustments	11.36M	794K	17.73M	25.58M	8.04M
Net Change in Cash	42.73M	-6.93M	13.2M	-5.1M	43.27M
Supplemental Items
Cash Interest Paid	67.81M	72.46M	70.78M	101M	132M
Cash Income Tax Paid (Refund)	54.06M	60.06M	75.44M	75.91M	90.37M
Levered Free Cash Flow	350M	270M	631M	299M	219M
Unlevered Free Cash Flow	388M	324M	677M	336M	304M
Change In Net Working Capital	-43.61M	75.73M	-172M	128M	174M
Net Debt Issued / Repaid	234M	30.59M	708M	19.79M	-75.32M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	5.37	5.4	6.34	5.63	5.19
Return on Total Capital	6.85	6.88	8.05	7.03	6.33
Return On Equity %	16.91	19.18	16.84	17.54	14.38
Return on Common Equity	17.07	19.43	16.82	17.65	14.44
Margin Analysis
Gross Profit Margin %	36.82	36.9	37.78	36.79	37.03
SG&A Margin	19.4	18.01	16.33	16.54	17.81
EBITDA Margin %	21.56	23.09	25.42	24.2	23.5
EBITA Margin %	17.42	18.88	21.45	20.25	19.22
EBIT Margin %